Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-26-183535
Filing Date
2026-04-28
Accepted
2026-04-28 07:24:06
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 d133316ds3.htm S-3 377596
2 EX-5.1 d133316dex51.htm EX-5.1 12275
3 EX-23.1 d133316dex231.htm EX-23.1 1553
4 EX-23.2 d133316dex232.htm EX-23.2 1538
5 EX-FILING FEES d133316dexfilingfees.htm   iXBRL EX-FILING FEES 18444
6 GRAPHIC g133316g03g03.jpg GRAPHIC 49445
7 GRAPHIC g133316g0426235705486.jpg GRAPHIC 3471
8 GRAPHIC g133316g08g08.jpg GRAPHIC 108362
  Complete submission text file 0001193125-26-183535.txt   740958

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT d133316dexfilingfees_htm.xml XML 5323
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-295362 | Film No.: 26903134
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)